MCID: CNG206
MIFTS: 46

Congenital Disorder of Glycosylation, Type Ie malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases, Muscle diseases, Liver diseases, Gastrointestinal diseases, Ear diseases, Fetal diseases, Bone diseases, Nephrological diseases, Cardiovascular diseases, Skin diseases, Blood diseases

Aliases & Classifications for Congenital Disorder of Glycosylation, Type Ie

About this section

Aliases & Descriptions for Congenital Disorder of Glycosylation, Type Ie:

Name: Congenital Disorder of Glycosylation, Type Ie 51 12 67
Congenital Disorder of Glycosylation, Type is 51 12 67
Dpm2-Cdg 11 47 24
Carbohydrate Deficient Glycoprotein Syndrome Type Ie 53 26
Congenital Disorder of Glycosylation, Type Iu 47 67
Congenital Disorder of Glycosylation Type is 69 26
Congenital Disorder of Glycosylation Type I 11 13
Congenital Disorder of Glycosylation 1u 24 26
Cdg1e 53 69
Congenital Muscular Dystrophy with Intellectual Disability and Severe Epilepsy 47
Cmd with Intellectual Disability and Severe Epilepsy 47
Carbohydrate Deficient Glycoprotein Syndrome Type Iu 47
Epileptic Encephalopathy, Early Infantile, 36 69
Congenital Disorder of Glycosylation Type 1u 47
Congenital Disorder of Glycosylation Type Iu 47
Congenital Disorder of Glycosylation Type 1e 53
Congenital Disorder of Glycosylation Type Ie 53
 
Congenital Disorder of Glycosylation 1s 69
Congenital Disorder of Glycosylation 1e 69
Congenital Disorder of Glycosylation Iu 24
Dol-P-Mannosyltransferase Deficiency 53
Cdg Syndrome Type Ie 53
Cdg Syndrome Type Iu 47
Dpm1-Cdg 53
Cdg-Iu 47
Cdg-Ie 53
Cdg-is 69
Eiee36 69
Cdg is 69
Cdg Iu 24
Cdgiu 24
Cdg1s 69
Cdgis 69
Cdg1u 47

Characteristics:

Orphanet epidemiological data:

53
carbohydrate deficient glycoprotein syndrome type ie:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal

HPO:

63
congenital disorder of glycosylation, type is:
Inheritance: x-linked recessive inheritance
Onset and clinical course: infantile onset
congenital disorder of glycosylation, type ie:
Inheritance: autosomal recessive inheritance
Onset and clinical course: infantile onset, progressive, variable expressivity

Classifications:



External Ids:

Disease Ontology11 DOID:0050570
Orphanet53 ORPHA79322
ICD10 via Orphanet30 E77.8

Summaries for Congenital Disorder of Glycosylation, Type Ie

About this section
UniProtKB/Swiss-Prot:69 Congenital disorder of glycosylation 1E: A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Some CDG1E patients have features consistent with a dystroglycanopathy and congenital muscular dystrophy, including O-mannosylation defect, camptodactyly, elevated creatine kinase, motor delay and dystrophic changes on muscel biopsy. Epileptic encephalopathy, early infantile, 36: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. Some EIEE36 patients may present with an abnormal isoelectric focusing of serum transferrin, consistent with a diagnostic classification of congenital disorder of glycosylation type I. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

MalaCards based summary: Congenital Disorder of Glycosylation, Type Ie, also known as congenital disorder of glycosylation, type is, is related to congenital disorder of glycosylation, type iu and epileptic encephalopathy, early infantile, 36, and has symptoms including microcephaly, seizures and muscular hypotonia. An important gene associated with Congenital Disorder of Glycosylation, Type Ie is DPM1 (Dolichyl-Phosphate Mannosyltransferase Subunit 1, Catalytic), and among its related pathways are Mineral absorption and N-Glycan biosynthesis. Affiliated tissues include eye.

Disease Ontology:11 A congenital disorder of glycosylation involve disrupted synthesis of the lipid-linked oligosaccharide precursor.

OMIM:51 Congenital disorders of glycosylation (CDGs) are metabolic deficiencies in glycoprotein biosynthesis that usually cause... (608799) more...

Description from OMIM:51 300884

Related Diseases for Congenital Disorder of Glycosylation, Type Ie

About this section

Diseases in the Congenital Disorder of Glycosylation 1aa family:

Congenital Disorder of Glycosylation, Type Ir Congenital Disorder of Glycosylation, Type It
Congenital Disorder of Glycosylation, Type Ic Congenital Disorder of Glycosylation, Type Io
Congenital Disorder of Glycosylation, Type Iz Congenital Disorder of Glycosylation, Type Iib
Congenital Disorder of Glycosylation, Type Ix Congenital Disorder of Glycosylation, Type in
Congenital Disorder of Glycosylation, Type Id Congenital Disorder of Glycosylation, Type Iq
Congenital Disorder of Glycosylation, Type Iik Congenital Disorder of Glycosylation, Type Iif
Congenital Disorder of Glycosylation, Type Iii Congenital Disorder of Glycosylation, Type Iid
Congenital Disorder of Glycosylation, Type Ii Congenital Disorder of Glycosylation, Type Iu
Congenital Disorder of Glycosylation, Type Im Congenital Disorder of Glycosylation, Type Ih
Congenital Disorder of Glycosylation, Type Iic Congenital Disorder of Glycosylation, Type Il
Congenital Disorder of Glycosylation, Type Ij Congenital Disorder of Glycosylation, Type Iw
Congenital Disorder of Glycosylation, Type Iil Congenital Disorder of Glycosylation, Type Ip
Congenital Disorder of Glycosylation, Type Iia Congenital Disorder of Glycosylation, Type Ib
Congenital Disorder of Glycosylation, Type Ik Congenital Disorder of Glycosylation, Type Ia
Congenital Disorder of Glycosylation, Type Iij Congenital Disorder of Glycosylation, Type Iih
Congenital Disorder of Glycosylation, Type if Congenital Disorder of Glycosylation, Type Iig
congenital disorder of glycosylation, type ie Congenital Disorder of Glycosylation, Type Ig
Congenital Disorder of Glycosylation, Type Iim Congenital Disorder of Glycosylation, Type Iy
Congenital Disorder of Glycosylation Type I/iix

Diseases related to Congenital Disorder of Glycosylation, Type Ie via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
idRelated DiseaseScoreTop Affiliating Genes
1congenital disorder of glycosylation, type iu12.3
2epileptic encephalopathy, early infantile, 3612.3
3congenital disorder of glycosylation type i/iix12.2
4congenital disorder of glycosylation, type iii11.0
5cog5-congenital disorder of glycosylation11.0
6congenital disorder of glycosylation, type ia11.0
7congenital disorder of glycosylation, type iid10.6
8congenital disorder of glycosylation, type ih10.6
9congenital disorder of glycosylation, type ig10.6
10periventricular heterotopia with microcephaly10.4PMM2, TF
11congenital disorder of glycosylation, type in10.4PMM2, TF
12postinflammatory pulmonary fibrosis10.3CP, TF
13macrocytic anemia10.3CP, TF
14cognitive impairment with or without cerebellar ataxia10.3CP, TF
15chronic lymphocytic leukemia10.3HP, TF
16hyperthyroxinemia10.3HP, TF
17scn8a encephalopathy10.3CP, TF
18spinal cord lipoma10.2CP, HP
19hydranencephaly10.2CP, HP
20transvestism10.2CP, HP
21balantidiasis10.1HP, TF
22myasthenic syndrome, congenital, 14, with tubular aggregates10.1SERPINA1, TF
23diphtheria10.1CP, TF
24acquired gastric outlet stenosis10.1CP, SERPINA1
25acute cervicitis10.1A2M, SERPINA1
26slate pneumoconiosis10.1SERPINA1, TF
27posterolateral myocardial infarction10.1A2M, SERPINA1
28paranasal sinus cancer, adult10.1CP, SERPINA1
29breast adenomyoepithelioma10.1CP, HP
30pulmonary disease, chronic obstructive10.1A2M, SERPINA1
31pompholyx10.0HP, SERPINA1
32chronic endophthalmitis10.0A2M, CP
33alcoholic liver cirrhosis10.0PMM2, TF
34xfe progeroid syndrome10.0HP, PMM2, TF
35spinal muscular atrophy, lower extremity-predominant, 2, ad10.0SERPINA1, TF
36caplan's syndrome10.0A2M, SERPINA1
37chronic closed-angle glaucoma10.0A2M, SERPINA1
38urinary bladder posterior wall cancer9.9CP, HP, TF
39tendinosis9.9CP, HEPH, TF
40rectal disease9.9CP, SERPINA1, TF
41eczematous dermatitis of eyelid9.9SERPINA1, TF
42posterior foramen magnum meningioma9.9SERPINA1, TF
43central nervous system adult germ cell tumor9.7HP, SERPINA1, TF
44lymphedema9.7HP, SERPINA1, TF
45vestibular nystagmus9.7HP, TF
46atransferrinemia9.5CP, HEPH, HP, TF
47nasu-hakola disease9.0CP, HEPH, HP, SERPINA1, TF
48ivic syndrome6.8A2M, ALG13, CP, DPM1, DPM2, HEPH

Graphical network of the top 20 diseases related to Congenital Disorder of Glycosylation, Type Ie:



Diseases related to congenital disorder of glycosylation, type ie

Symptoms for Congenital Disorder of Glycosylation, Type Ie

About this section

Symptoms by clinical synopsis from OMIM:

300884

Clinical features from OMIM:

608799,300884

Human phenotypes related to Congenital Disorder of Glycosylation, Type Ie:

 63 53 (show all 56)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 microcephaly63 53 hallmark (90%) Very frequent (99-80%) HP:0000252
2 seizures63 53 hallmark (90%) Very frequent (99-80%) HP:0001250
3 muscular hypotonia63 53 hallmark (90%) Very frequent (99-80%) HP:0001252
4 cognitive impairment63 hallmark (90%) HP:0100543
5 hydrocephalus63 rare (5%) HP:0000238
6 flexion contracture63 rare (5%) HP:0001371
7 abnormal facial shape63 rare (5%) HP:0001999
8 abnormal pyramidal signs63 rare (5%) HP:0007256
9 optic atrophy63 HP:0000648
10 horizontal nystagmus63 HP:0000666
11 global developmental delay63 HP:0001263
12 abnormality of extrapyramidal motor function63 HP:0002071
13 hepatomegaly63 HP:0002240
14 recurrent infections63 HP:0002719
15 type i transferrin isoform profile63 HP:0003642
16 hypertelorism63 HP:0000316
17 smooth philtrum63 HP:0000319
18 micrognathia63 HP:0000347
19 strabismus63 HP:0000486
20 retinopathy63 HP:0000488
21 downslanted palpebral fissures63 HP:0000494
22 nystagmus63 HP:0000639
23 telangiectasia63 HP:0001009
24 hemangioma63 HP:0001028
25 abnormality of the macula63 HP:0001103
26 ataxia63 HP:0001251
27 tremor63 HP:0001337
28 failure to thrive63 HP:0001508
29 patent ductus arteriosus63 HP:0001643
30 splenomegaly63 HP:0001744
31 reduced antithrombin iii activity63 HP:0001976
32 respiratory distress63 HP:0002098
33 nail dysplasia63 HP:0002164
34 eeg abnormality63 HP:0002353
35 lower limb hyperreflexia63 HP:0002395
36 high, narrow palate63 HP:0002705
37 elevated hepatic transaminases63 HP:0002910
38 elevated serum creatine phosphokinase63 HP:0003236
39 muscular dystrophy63 HP:0003560
40 prolonged partial thromboplastin time63 HP:0003645
41 short palm63 HP:0004279
42 reduced protein s activity63 HP:0004855
43 depressed nasal bridge63 HP:0005280
44 flat occiput63 HP:0005469
45 postnatal microcephaly63 HP:0005484
46 reduced protein c activity63 HP:0005543
47 knee flexion contracture63 HP:0006380
48 ankle contracture63 HP:0006466
49 pontocerebellar atrophy63 HP:0006879
50 upper limb undergrowth63 HP:0009824
51 severe global developmental delay63 53 Very frequent (99-80%) HP:0011344
52 camptodactyly63 HP:0012385
53 cortical visual impairment63 HP:0100704
54 small hand63 HP:0200055
55 abnormality of the eye53 Very frequent (99-80%)
56 abnormality of vision53 Very frequent (99-80%)

UMLS symptoms related to Congenital Disorder of Glycosylation, Type Ie:


ataxia, diarrhea, hepatomegaly, seizures, vomiting, weakness, cerebellar ataxia, tremor, respiratory distress, myopathic facies

Drugs & Therapeutics for Congenital Disorder of Glycosylation, Type Ie

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Congenital Disorder of Glycosylation, Type Ie

Genetic Tests for Congenital Disorder of Glycosylation, Type Ie

About this section

Genetic tests related to Congenital Disorder of Glycosylation, Type Ie:

id Genetic test Affiliating Genes
1 Carbohydrate-Deficient Glycoprotein Syndrome Type I26
2 Congenital Disorder of Glycosylation Type 1e26
3 Congenital Disorder of Glycosylation Type 1u26
4 Congenital Disorder of Glycosylation Type 1y26
5 Dpm2-Cdg (cdg-Iu)24 DPM2

Anatomical Context for Congenital Disorder of Glycosylation, Type Ie

About this section

MalaCards organs/tissues related to Congenital Disorder of Glycosylation, Type Ie:

35
Eye

Animal Models for Congenital Disorder of Glycosylation, Type Ie or affiliated genes

About this section

Publications for Congenital Disorder of Glycosylation, Type Ie

About this section

Articles related to Congenital Disorder of Glycosylation, Type Ie:

idTitleAuthorsYear
1
Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. (10642602)
2000

Variations for Congenital Disorder of Glycosylation, Type Ie

About this section

UniProtKB/Swiss-Prot genetic disease variations for Congenital Disorder of Glycosylation, Type Ie:

69
id Symbol AA change Variation ID SNP ID
1ALG13p.Lys94GluVAR_069218rs867599353
2ALG13p.Asn107SerVAR_069412rs398122394
3DPM1p.Arg92GlyVAR_012341rs121908583
4DPM1p.Ser248ProVAR_019841rs587777114
5DPM1p.Gly152ValVAR_070592rs587777116

Clinvar genetic disease variations for Congenital Disorder of Glycosylation, Type Ie:

5 (show all 41)
id Gene Variation Type Significance SNP ID Assembly Location
1DPM1NM_003859.2(DPM1): c.742T> C (p.Ser248Pro)SNVPathogenicrs587777114GRCh37Chr 20, 49551710: 49551710
2DPM1NM_003859.2(DPM1): c.373-5T> ASNVPathogenicrs587777115GRCh37Chr 20, 49562304: 49562304
3DPM1NM_003859.2(DPM1): c.455G> T (p.Gly152Val)SNVPathogenicrs587777116GRCh37Chr 20, 49558607: 49558607
4DPM1NG_008923.1: g.(8339_14860)_(22659_27261)deldeletionPathogenicGRCh38Chr 20, 50936263: 50955185
5PMM2NM_000303.2(PMM2): c.470T> C (p.Phe157Ser)SNVLikely pathogenic, Pathogenicrs190521996GRCh38Chr 16, 8811660: 8811660
6PMM2NM_000303.2(PMM2): c.442G> A (p.Asp148Asn)SNVPathogenicrs148032587GRCh37Chr 16, 8905030: 8905030
7PMM2NM_000303.2(PMM2): c.415G> A (p.Glu139Lys)SNVPathogenicrs80338703GRCh37Chr 16, 8905003: 8905003
8PMM2NM_000303.2(PMM2): c.653A> T (p.His218Leu)SNVPathogenicrs80338705GRCh37Chr 16, 8941594: 8941594
9PMM2NM_000303.2(PMM2): c.710C> T (p.Thr237Met)SNVLikely pathogenic, Pathogenicrs80338708GRCh37Chr 16, 8941651: 8941651
10PMM2NM_000303.2(PMM2): c.317A> T (p.Tyr106Phe)SNVPathogenicrs387906824GRCh37Chr 16, 8900234: 8900234
11DPM2NM_003863.3(DPM2): c.68A> G (p.Tyr23Cys)SNVPathogenicrs397514503GRCh37Chr 9, 130699738: 130699738
12DPM2NM_003863.3(DPM2): c.4_93del90SNVPathogenicrs797044467GRCh38Chr 9, 127937524: 127937524
13ALG13NM_001099922.2(ALG13): c.339A> G (p.Ala113=)SNVPathogenicrs397514587GRCh37Chr X, 110928287: 110928287
14DPM1NM_003859.2(DPM1): c.274C> G (p.Arg92Gly)SNVPathogenicrs121908583GRCh37Chr 20, 49565187: 49565187
15DPM1DPM1, 13-BP DELdeletionPathogenicChr na, -1: -1
16DPM1DPM1, 1-BP DEL, 628CdeletionPathogenicChr na, -1: -1
17ALG13NM_001257235.2(ALG13): c.8A> G (p.Asn3Ser)SNVPathogenicrs398122394GRCh37Chr X, 110928268: 110928268
18PMM2NM_000303.2(PMM2): c.422G> A (p.Arg141His)SNVPathogenicrs28936415GRCh37Chr 16, 8905010: 8905010
19PMM2NM_000303.2(PMM2): c.647A> T (p.Asn216Ile)SNVPathogenicrs78290141GRCh37Chr 16, 8941588: 8941588
20PMM2NM_000303.2(PMM2): c.385G> A (p.Val129Met)SNVLikely pathogenic, Pathogenicrs104894525GRCh37Chr 16, 8904973: 8904973
21PMM2NM_000303.2(PMM2): c.484C> T (p.Arg162Trp)SNVLikely pathogenic, Pathogenicrs104894526GRCh37Chr 16, 8905531: 8905531
22PMM2NM_000303.2(PMM2): c.193G> T (p.Asp65Tyr)SNVPathogenicrs104894527GRCh37Chr 16, 8898638: 8898638
23PMM2NM_000303.2(PMM2): c.357C> A (p.Phe119Leu)SNVPathogenicrs80338701GRCh37Chr 16, 8904945: 8904945
24PMM2NM_000303.2(PMM2): c.563A> G (p.Asp188Gly)SNVPathogenicrs80338704GRCh37Chr 16, 8906887: 8906887
25PMM2NM_000303.2(PMM2): c.349G> C (p.Gly117Arg)SNVPathogenicrs104894530GRCh37Chr 16, 8904937: 8904937
26PMM2NM_000303.2(PMM2): c.669C> G (p.Asp223Glu)SNVPathogenicrs104894531GRCh37Chr 16, 8941610: 8941610
27PMM2PMM2, 357C-ASNVPathogenicChr na, -1: -1
28PMM2NM_000303.2(PMM2): c.710C> G (p.Thr237Arg)SNVPathogenicrs80338708GRCh37Chr 16, 8941651: 8941651
29PMM2NM_000303.2(PMM2): c.722G> C (p.Cys241Ser)SNVPathogenicrs80338709GRCh37Chr 16, 8941663: 8941663
30PMM2NM_000303.2(PMM2): c.395T> C (p.Ile132Thr)SNVLikely pathogenic, Pathogenicrs80338702GRCh37Chr 16, 8904983: 8904983
31PMM2NM_000303.2(PMM2): c.691G> A (p.Val231Met)SNVPathogenicrs80338707GRCh37Chr 16, 8941632: 8941632
32PMM2NM_000303.2(PMM2): c.26G> A (p.Cys9Tyr)SNVLikely pathogenic, Pathogenicrs104894532GRCh37Chr 16, 8891765: 8891765
33PMM2NM_000303.2(PMM2): c.95T> G (p.Leu32Arg)SNVPathogenicrs104894533GRCh37Chr 16, 8895684: 8895684
34PMM2NM_000303.2(PMM2): c.677C> G (p.Thr226Ser)SNVPathogenicrs80338706GRCh37Chr 16, 8941618: 8941618
35PMM2NM_000303.2(PMM2): c.338C> T (p.Pro113Leu)SNVPathogenicrs80338700GRCh37Chr 16, 8900255: 8900255
36PMM2PMM2, IVS7, C-TSNVPathogenicChr na, -1: -1
37PMM2NM_000303.2(PMM2): c.131T> C (p.Val44Ala)SNVLikely pathogenic, Pathogenicrs104894534GRCh37Chr 16, 8895720: 8895720
38PMM2PMM2, 28-KB DELdeletionPathogenicChr na, -1: -1
39PMM2PMM2, IVS3AS, G-C, -1SNVPathogenicChr na, -1: -1
40PMM2NM_000303.2(PMM2): c.623G> C (p.Gly208Ala)SNVPathogenicrs398123309GRCh37Chr 16, 8906947: 8906947
41PMM2NM_000303.2(PMM2): c.95_96delTAinsGC (p.Leu32Arg)indelLikely pathogenic, Pathogenicrs398123312GRCh37Chr 16, 8895684: 8895685

Expression for genes affiliated with Congenital Disorder of Glycosylation, Type Ie

About this section
Search GEO for disease gene expression data for Congenital Disorder of Glycosylation, Type Ie.

Pathways for genes affiliated with Congenital Disorder of Glycosylation, Type Ie

About this section

GO Terms for genes affiliated with Congenital Disorder of Glycosylation, Type Ie

About this section

Cellular components related to Congenital Disorder of Glycosylation, Type Ie according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dolichol-phosphate-mannose synthase complexGO:00331859.6DPM1, DPM2
2platelet alpha granule lumenGO:00310939.5A2M, SERPINA1
3blood microparticleGO:00725628.7A2M, CP, HP, TF

Biological processes related to Congenital Disorder of Glycosylation, Type Ie according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1dolichol metabolic processGO:00193489.9DPM1, DPM2
2copper ion transportGO:00068259.9CP, HEPH
3protein O-linked mannosylationGO:00352699.9DPM1, DPM2
4protein N-linked glycosylation via asparagineGO:00182799.8DPM1, DPM2
5acute-phase responseGO:00069539.6HP, SERPINA1
6GPI anchor biosynthetic processGO:00065069.6DPM1, DPM2
7cellular iron ion homeostasisGO:00068799.5CP, HEPH, TF
8platelet degranulationGO:00025769.3A2M, SERPINA1, TF

Molecular functions related to Congenital Disorder of Glycosylation, Type Ie according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dolichyl-phosphate beta-D-mannosyltransferase activityGO:00045829.9DPM1, DPM2
2ferroxidase activityGO:00043229.7CP, HEPH
3copper ion bindingGO:00055079.6CP, HEPH
4ferrous iron bindingGO:00081989.6HEPH, TF

Sources for Congenital Disorder of Glycosylation, Type Ie

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet